» Articles » PMID: 7700644

Frequent Loss of Imprinting of the H19 Gene is Often Associated with Its Overexpression in Human Lung Cancers

Overview
Journal Oncogene
Date 1995 Mar 16
PMID 7700644
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests that deregulation of the insulin-like growth factor II (IGF2) and H19 genes at 11p15, due to loss of imprinting (LOI), plays a role in the oncogenesis of Wilms' tumors. We previously reported LOI of IGF2 in carcinomas of the lung, a common cancer of adults. We show here that LOI of H19 is also a frequent event in lung cancer development, and correlated with hypomethylation of the promoter region. Furthermore, the present study also revealed that overexpression of H19 is often associated with LOI of H19 in lung cancers retaining both parental alleles, showing a contrast to LOI in Wilms' tumors. Interestingly, in contrast to frequent LOI of the imprinted genes at 11p15, LOI was not observed for the remaining gene known to be imprinted in man, SNRPN at 15q12.

Citing Articles

lncRNAs regulate cell stemness in physiology and pathology during differentiation and development.

Lu J, Xu L, Wang Y, Guan B Am J Stem Cells. 2024; 13(2):59-74.

PMID: 38765805 PMC: 11101988. DOI: 10.62347/VHVU7361.


Transcription regulation by long non-coding RNAs: mechanisms and disease relevance.

Ferrer J, Dimitrova N Nat Rev Mol Cell Biol. 2024; 25(5):396-415.

PMID: 38242953 PMC: 11045326. DOI: 10.1038/s41580-023-00694-9.


Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis.

Liu H, Sun L, Liu X, Wang R, Luo Q Medicine (Baltimore). 2023; 102(39):e35257.

PMID: 37773807 PMC: 10545158. DOI: 10.1097/MD.0000000000035257.


Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study.

Rolla M, Jawiarczyk-Przybylowska A, Kolackov K, Zembska A, Bolanowski M Biomedicines. 2023; 11(4).

PMID: 37189829 PMC: 10136071. DOI: 10.3390/biomedicines11041211.


Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression.

Aliquo F, Minuti A, Avenoso A, Mandraffino G, Campo G, Campo S Int J Mol Sci. 2023; 24(9).

PMID: 37175885 PMC: 10179037. DOI: 10.3390/ijms24098178.